Companies / Prelude Therapeutics Incorporated / Activity
Activity — Prelude Therapeutics Incorporated
13 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Orbimed Advisors LLC Director | Buy | Common Stock | $7.50M | +1.7M +16.69% | 11,808,945 14.80% of shares | high |
| Apr 21, 2026 | Orbimed Advisors LLC Director | Buy | Common Stock | $5.00M | +1.1M | 1,126,126 1.41% of shares | high |
| Apr 27, 2026 | RA Capital Management, L.P. 10% owner | Other | Pre-Funded Warrants (Right to Buy) | — | +1.4M | 1,407,000 1.76% of shares | low |
| Apr 27, 2026 | RA Capital Management, L.P. 10% owner | Other | Common Stock | — | -1.4M -17.85% | 6,475,882 8.11% of shares | low |
| Jun 9, 2026 | Friedman Paul a Director | Grant | Director Stock Option (Right to Buy) | — | +38K | 38,000 0.05% of shares | low |
| Jun 9, 2026 | Baker Bros. Advisors LP Director | Grant | Non-Qualified Stock Option (right to buy) | — | +38K | 38,000 0.05% of shares | low |
| Jun 9, 2026 | Baker Bros. Advisors LP Director | Grant | Non-Qualified Stock Option (right to buy) | — | +38K | 38,000 0.05% of shares | low |
| Apr 21, 2026 | Baker Bros. Advisors LP Director | Buy | Warrants to purchase Common Stock | — | +2.1M +11.90% | 20,105,994 25.19% of shares | low |
| Apr 21, 2026 | Baker Bros. Advisors LP Director | Buy | Warrants to purchase Common Stock | — | +115K +7.33% | 1,678,273 2.10% of shares | low |
| Feb 4, 2026 | Combs Andrew Executive | Grant | Employee Stock Option (right to buy) | — | +230K | 230,000 0.29% of shares | low |
| Feb 4, 2026 | Vaddi Krishna CEO | Grant | Employee Stock Option (right to buy) | — | +837K | 837,000 1.05% of shares | low |
| Feb 4, 2026 | Scherle Peggy Executive | Grant | Employee Stock Option (right to buy) | — | +230K | 230,000 0.29% of shares | low |
| Feb 4, 2026 | Lim Bryant David Executive | Grant | Employee Stock Option (right to buy) | — | +275K | 275,000 0.34% of shares | low |